Takeda Stock Price Falls Following Actos Suspension

BMI Core View: Post-marketing surveillance trials will become standard in the pharmaceutical industry. Currently, these phase IV studies are infrequently employed, mainly due to the significant cost of monitoring several thousand patients over a long period of time. However, a series of high-profile product recalls, as well as safety concerns regarding drugs mean that regulators and drugmakers will be encouraged to intensively study medicines after approval.

To read the full article, please choose one of the following options: